002365 永安药业
交易中 09-16 14:34:57
资讯
新帖
简况
异动快报：永安药业（002365）9月10日15点0分触及跌停板
证券之星 · 09-10
异动快报：永安药业（002365）9月10日15点0分触及跌停板
【机构调研记录】泰康基金调研永安药业、宇信科技
证券之星 · 09-10
【机构调研记录】泰康基金调研永安药业、宇信科技
异动快报：永安药业（002365）9月8日10点42分触及涨停板
证券之星 · 09-08
异动快报：永安药业（002365）9月8日10点42分触及涨停板
永安药业(002365)8月31日股东户数5.71万户，较上期减少3.04%
证券之星 · 09-07
永安药业(002365)8月31日股东户数5.71万户，较上期减少3.04%
公司问答丨永安药业：牛磺酸在医药领域的应用占比相对较小 目前主要应用于食品、饮料、饲料行业
格隆汇 · 09-07
公司问答丨永安药业：牛磺酸在医药领域的应用占比相对较小 目前主要应用于食品、饮料、饲料行业
股市必读：永安药业(002365)股东户数5.89万户，较上期增加37.32%
证券之星 · 09-01
股市必读：永安药业(002365)股东户数5.89万户，较上期增加37.32%
股市必读：永安药业新发布《2026年半年度报告摘要》
证券之星 · 08-31
股市必读：永安药业新发布《2026年半年度报告摘要》
永安药业（002365）2026年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-29
永安药业（002365）2026年中报简析：营收净利润同比双双增长，应收账款上升
永安药业（002365）披露2026年半年度报告，8月27日股价下跌0.6%
证券之星 · 08-27
永安药业（002365）披露2026年半年度报告，8月27日股价下跌0.6%
永安药业(002365)6月30日股东户数4.29万户，较上期增加1.02%
证券之星 · 08-27
永安药业(002365)6月30日股东户数4.29万户，较上期增加1.02%
永安药业(002365.SZ)发布半年度业绩，归母净利润4340.83万元，同比增长247.39%
智通财经 · 08-27
永安药业(002365.SZ)发布半年度业绩，归母净利润4340.83万元，同比增长247.39%
8月19日永安药业（002365）龙虎榜数据：机构净买入1332.8万元，北向资金净卖出386.44万元
证券之星 · 08-19
8月19日永安药业（002365）龙虎榜数据：机构净买入1332.8万元，北向资金净卖出386.44万元
异动快报：永安药业（002365）8月18日9点32分触及涨停板
证券之星 · 08-18
异动快报：永安药业（002365）8月18日9点32分触及涨停板
股市必读：永安药业新发布《关于取得发明专利证书的公告》
证券之星 · 08-13
股市必读：永安药业新发布《关于取得发明专利证书的公告》
永安药业（002365）披露取得发明专利证书公告，8月11日股价下跌1.68%
证券之星 · 08-11
永安药业（002365）披露取得发明专利证书公告，8月11日股价下跌1.68%
股市必读：永安药业新发布《关于购买理财产品的进展公告》
证券之星 · 08-06
股市必读：永安药业新发布《关于购买理财产品的进展公告》
股市必读：永安药业新发布《关于购买理财产品的进展公告》
证券之星 · 08-05
股市必读：永安药业新发布《关于购买理财产品的进展公告》
永安药业(002365)6月30日股东户数4.29万户，较上期增加1.02%
证券之星 · 07-27
永安药业(002365)6月30日股东户数4.29万户，较上期增加1.02%
永安药业（002365）披露增加与湖北永邦关联交易额度公告，7月22日股价上涨2.55%
证券之星 · 07-22
永安药业（002365）披露增加与湖北永邦关联交易额度公告，7月22日股价上涨2.55%
股市必读：永安药业（002365）登7月17日交易所龙虎榜
证券之星 · 07-20
股市必读：永安药业（002365）登7月17日交易所龙虎榜
暂无数据
公司概况
公司名称：
潜江永安药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-03-05
主营业务：
潜江永安药业股份有限公司的主营业务是牛磺酸产品、保健食品、特殊膳食食品（肌酸）的研发、生产和销售。公司的主要产品是牛磺酸、保健食品、特殊膳食食品（一水肌酸）。公司连续多年被湖北省科学技术厅、湖北省财政厅、国家税务总局湖北省税务局认定为“高新技术企业”。
发行价格：
31.00
{"stockData":{"symbol":"002365","market":"SZ","secType":"STK","nameCN":"永安药业","latestPrice":13.93,"timestamp":1789540497000,"preClose":14.02,"halted":0,"volume":11984400,"delay":0,"changeRate":-0.0064,"floatShares":246000000,"shares":295000000,"eps":0.1813,"marketStatus":"交易中","change":-0.09,"latestTime":"09-16 14:34:57","open":13.95,"high":14.23,"low":13.8,"amount":168000000,"amplitude":0.0307,"askPrice":13.94,"askSize":132,"bidPrice":13.93,"bidSize":524,"shortable":0,"etf":0,"ttmEps":0.1813,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789542000000},"marketStatusCode":2,"adr":0,"adjPreClose":14.02,"symbolType":"stock","openAndCloseTimeList":[[1789522200000,1789529400000],[1789534800000,1789542000000]],"highLimit":15.42,"lowLimit":12.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":294682500,"isCdr":false,"pbRate":2.06,"roa":"--","peRate":76.833977,"roe":"2.16%","epsLYR":0.0777,"committee":0.549971,"marketValue":4105000000,"turnoverRate":0.0488,"status":1,"floatMarketCap":3422000000},"requestUrl":"/m/hq/s/002365/tweets","defaultTab":"tweets","newsList":[{"id":"2666568719","title":"异动快报：永安药业（002365）9月10日15点0分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2666568719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666568719?lang=zh_cn&edition=full","pubTime":"2026-09-10 15:01","pubTimestamp":1789023663,"startTime":"0","endTime":"0","summary":"证券之星9月10日盘中消息，15点0分永安药业（002365）触及跌停板。其所属行业化学制药目前下跌。领涨股为津药药业。该股为石墨烯，氢能源/燃料电池，碳基材料概念热股。9月9日的资金流向数据方面，主力资金净流出8036.28万元，占总成交额12.0%，游资资金净流出1712.19万元，占总成交额2.56%，散户资金净流入9748.48万元，占总成交额14.56%。近5日资金流向一览见下表：永安药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000021483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002365","BK0086","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666556235","title":"【机构调研记录】泰康基金调研永安药业、宇信科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2666556235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666556235?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:06","pubTimestamp":1788998789,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月9日披露的机构调研信息，泰康基金近期对2家上市公司进行了调研，相关名单如下：1）永安药业 调研纪要：今年上半年牛磺酸销量和价格提升，带动业绩同比大幅上涨。牛磺酸出口占比约80%，内销逐步增加。2）宇信科技 调研纪要：AI不会侵蚀懂业务的软件公司，反而催生更大行业需求。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000005993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300674","BK0231","002365","BK0086","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341042","title":"异动快报：永安药业（002365）9月8日10点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341042","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665341042?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:50","pubTimestamp":1788835829,"startTime":"0","endTime":"0","summary":"证券之星9月8日盘中消息，10点42分永安药业（002365）触及涨停板。其所属行业化学制药目前上涨。领涨股为东亚药业。该股为食品，饲料，碳基材料概念热股，当日食品概念上涨1.25%，饲料概念上涨1.14%，碳基材料概念上涨1.0%。9月7日的资金流向数据方面，主力资金净流入1261.54万元，占总成交额3.5%，游资资金净流出640.84万元，占总成交额1.78%，散户资金净流出620.7万元，占总成交额1.72%。近5日资金流向一览见下表：永安药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800012469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002365","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314846","title":"永安药业(002365)8月31日股东户数5.71万户，较上期减少3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314846","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314846?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:47","pubTimestamp":1788774451,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2026年8月31日公司股东户数为5.71万户，较8月20日减少1792.0户，减幅为3.04%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至8月31日，化学制药行业平均股东户数为3.65万户。从股价来看，2026年8月20日至2026年8月31日，永安药业区间跌幅为3.49%，在此期间股东户数减少1792.0户，减幅为3.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0086","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665933313","title":"公司问答丨永安药业：牛磺酸在医药领域的应用占比相对较小 目前主要应用于食品、饮料、饲料行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2665933313","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665933313?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:28","pubTimestamp":1788773283,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002365","159938","159151","BK0086","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000619","title":"股市必读：永安药业(002365)股东户数5.89万户，较上期增加37.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664000619?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:37","pubTimestamp":1788201434,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，永安药业报收于15.21元，下跌1.17%，换手率17.97%，成交量44.13万手，成交额6.73亿元。股本股东变化：截至2026年8月20日，公司股东户数为5.89万户，较6月30日增加37.32%。股本股东变化股东户数变动截至2026年8月20日公司股东户数为5.89万户，较6月30日增加1.6万户，增幅为37.32%；户均持股数量由上期的5152.0股减少至5000.0股，户均持股市值为7.88万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0239","002365"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663042142","title":"股市必读：永安药业新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663042142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663042142?lang=zh_cn&edition=full","pubTime":"2026-08-31 02:23","pubTimestamp":1788114189,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，永安药业报收于15.39元，上涨3.01%，换手率21.65%，成交量53.18万手，成交额7.93亿元。公司公告汇总：2026年半年度营业收入同比增长53.44%，归属于上市公司股东的净利润同比增长247.39%。公司公告汇总：公司与浙江双子智能装备有限公司签订不超过1000万元的设备制造及系统集成供应框架协议，构成关联交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","002365","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016110","title":"永安药业（002365）2026年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016110?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:27","pubTimestamp":1787956020,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期永安药业发布2026年中报。截至本报告期末，公司营业总收入5.64亿元，同比上升53.44%，归母净利润4340.83万元，同比上升247.39%。按单季度数据看，第二季度营业总收入3.28亿元，同比上升67.06%，第二季度归母净利润3567.16万元，同比上升111.54%。本报告期永安药业应收账款上升，应收账款同比增幅达72.93%。本文数据来源于永安药业2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900011300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662085303","title":"永安药业（002365）披露2026年半年度报告，8月27日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662085303","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662085303?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:05","pubTimestamp":1787839505,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，永安药业报收于14.94元，较前一交易日下跌0.6%，最新总市值为44.03亿元。该股当日开盘14.9元，最高15.4元，最低14.52元，成交额达6.57亿元，换手率为17.94%。近日，永安药业披露《2026年半年度报告》。归属于上市公司股东的净利润为43,408,294.20元，上年同期为12,495,723.72元，同比增长247.39%。经营活动产生的现金流量净额为32,090,494.90元，上年同期为51,181,550.62元，同比下降37.30%。归属于上市公司股东的净资产为2,002,355,747.59元，上年度末为1,987,008,294.36元，增长0.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700054465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0028","002365","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662842703","title":"永安药业(002365)6月30日股东户数4.29万户，较上期增加1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662842703","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662842703?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:08","pubTimestamp":1787825326,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2026年6月30日公司股东户数为4.29万户，较6月18日增加435.0户，增幅为1.02%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年6月18日至2026年6月30日，永安药业区间跌幅为5.15%，在此期间股东户数增加435.0户，增幅为1.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002365","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771507","title":"永安药业(002365.SZ)发布半年度业绩，归母净利润4340.83万元，同比增长247.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771507","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662771507?lang=zh_cn&edition=full","pubTime":"2026-08-27 16:13","pubTimestamp":1787818389,"startTime":"0","endTime":"0","summary":"智通财经APP讯，永安药业(002365.SZ)发布2026年半年度报告，报告期内，公司实现营业收入5.64亿元，较去年同期增长53.44%;实现归属于上市公司股东的净利润4340.83万元，较去年同期增长247.39%;实现归属于上市公司股东的扣除非经常性损益的净利润3936.16万元，较去年同期增长1622.35%;基本每股收益0.1501元。报告期内，牛磺酸业务持续发力，产品销量与销价较上年同期均明显提升，带动公司业绩大幅增长;保健食品业务各项工作扎实推进，发展根基进一步夯实;一水肌酸业务扭转前期经营劣势，盈利水平稳步回升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"永安药业(002365.SZ)发布半年度业绩，归母净利润4340.83万元，同比增长247.39%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002365"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660844474","title":"8月19日永安药业（002365）龙虎榜数据：机构净买入1332.8万元，北向资金净卖出386.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660844474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660844474?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:20","pubTimestamp":1787134810,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月19日公布的交易公开信息显示，永安药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月19日收盘，永安药业报收于14.33元，下跌7.85%，换手率23.83%，成交量58.44万手，成交额8.47亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1332.8万元，北向资金合计净卖出386.44万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900032102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002365","BK0086","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660950455","title":"异动快报：永安药业（002365）8月18日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2660950455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660950455?lang=zh_cn&edition=full","pubTime":"2026-08-18 09:35","pubTimestamp":1787016952,"startTime":"0","endTime":"0","summary":"证券之星8月18日盘中消息，9点32分永安药业（002365）触及涨停板。其所属行业化学制药目前上涨。领涨股为冀衡医药。该股为饲料，食品，保健品概念热股，当日饲料概念上涨1.16%，食品概念上涨0.74%，保健品概念上涨0.41%。8月17日的资金流向数据方面，主力资金净流入7537.55万元，占总成交额15.73%，游资资金净流出3845.8万元，占总成交额8.03%，散户资金净流出3691.75万元，占总成交额7.7%。近5日资金流向一览见下表：永安药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800009606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002365","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659011009","title":"股市必读：永安药业新发布《关于取得发明专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659011009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659011009?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:00","pubTimestamp":1786554046,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，永安药业报收于13.52元，上涨0.52%，换手率7.53%，成交量18.46万手，成交额2.49亿元。当日关注点交易信息汇总：8月12日主力资金净流出1123.39万元，占总成交额4.52%。公司公告汇总：永安药业于2026年8月7日获授发明专利“一种连续制备羟乙基磺酸钠的方法及系统”，专利号ZL 2023 1 0738883.5。该专利涉及羟乙基磺酸钠的制备方法及系统，其为牛磺酸、日化洗护及精细化工产品的中间体，应用于医药、日用化工等领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300000864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0028","002365"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916182","title":"永安药业（002365）披露取得发明专利证书公告，8月11日股价下跌1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916182","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658916182?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:05","pubTimestamp":1786457104,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，永安药业报收于13.45元，较前一交易日下跌1.68%，最新总市值为39.63亿元。该股当日开盘13.52元，最高13.88元，最低13.44元，成交额达3.73亿元，换手率为11.15%。近日，潜江永安药业股份有限公司获得一项发明专利证书，发明名称为“一种连续制备羟乙基磺酸钠的方法及系统”，专利号ZL 2023 1 0738883.5，申请日为2023年6月21日，授权公告日为2026年8月7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100037838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","002365","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521614","title":"股市必读：永安药业新发布《关于购买理财产品的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657521614?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:29","pubTimestamp":1785950951,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，永安药业报收于12.75元，下跌0.16%，换手率8.01%，成交量19.65万手，成交额2.49亿元。公司公告汇总：截至公告日，永安药业未到期理财产品余额为5.4亿元，占最近一期经审计净资产的27.18%。公司公告汇总关于购买理财产品的进展公告潜江永安药业股份有限公司于2026年5月至8月期间，使用自有资金合计1.285亿元购买多款理财产品，涉及长江期货、广发证券、长江证券、中金财富、中信证券、国泰海通等机构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","002365","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568481","title":"股市必读：永安药业新发布《关于购买理财产品的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657568481?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:09","pubTimestamp":1785863351,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，永安药业报收于12.77元，上涨1.19%，换手率9.16%，成交量22.48万手，成交额2.87亿元。公司公告汇总：截至公告日，永安药业未到期理财产品余额为5.4亿元，占最近一期经审计净资产的27.18%，未超过股东会授权额度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0086","002365"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654544016","title":"永安药业(002365)6月30日股东户数4.29万户，较上期增加1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654544016","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654544016?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:35","pubTimestamp":1785144946,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2026年6月30日公司股东户数为4.29万户，较6月18日增加435.0户，增幅为1.02%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年6月18日至2026年6月30日，永安药业区间跌幅为5.15%，在此期间股东户数增加435.0户，增幅为1.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0028","002365"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653765427","title":"永安药业（002365）披露增加与湖北永邦关联交易额度公告，7月22日股价上涨2.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653765427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653765427?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:10","pubTimestamp":1784729431,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，永安药业报收于12.48元，较前一交易日上涨2.55%，最新总市值为36.78亿元。近日，永安药业披露《关于增加与湖北永邦工程技术有限公司关联交易额度的公告》。公告显示，公司于2026年7月22日召开董事会，审议通过增加与湖北永邦工程技术有限公司关联交易额度的议案，将原不超过2,000万元的交易额度增加2,000万元，调整后总额度不超过4,000万元。独立董事已发表同意意见，本次事项无需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","002365","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652252450","title":"股市必读：永安药业（002365）登7月17日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2652252450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652252450?lang=zh_cn&edition=full","pubTime":"2026-07-20 01:18","pubTimestamp":1784481490,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，永安药业报收于12.6元，下跌4.4%，换手率26.39%，成交量64.74万手，成交额8.49亿元。龙虎榜上榜永安药业因日换手率达到20%的前5只证券，登上沪深交易所2026年7月17日交易公开信息龙虎榜；此次为近5个交易日内第2次上榜。公司公告汇总股票交易异常波动公告潜江永安药业股份有限公司股票交易价格于2026年7月15日、16日连续两个交易日内日收盘价格涨幅偏离值累计超过20%，构成股票交易异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000000640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0028","BK0086","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789540500142,"stockEarnings":[{"period":"1week","weight":-0.1281},{"period":"1month","weight":0.0605},{"period":"3month","weight":0.3054},{"period":"6month","weight":0.0119},{"period":"1year","weight":-0.227},{"period":"ytd","weight":-0.0519}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.0355},{"period":"1year","weight":0.001},{"period":"ytd","weight":-0.0263}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"潜江永安药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"57147人(较上一季度减少3.04%)","perCapita":"4298股","listingDate":"2010-03-05","address":"湖北省潜江市经济开发区广泽大道2号","registeredCapital":"29468万元","survey":" 潜江永安药业股份有限公司的主营业务是牛磺酸产品、保健食品、特殊膳食食品（肌酸）的研发、生产和销售。公司的主要产品是牛磺酸、保健食品、特殊膳食食品（一水肌酸）。公司连续多年被湖北省科学技术厅、湖北省财政厅、国家税务总局湖北省税务局认定为“高新技术企业”。","listedPrice":31},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供永安药业(002365)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"永安药业,002365,永安药业股票,永安药业股票老虎,永安药业股票老虎国际,永安药业行情,永安药业股票行情,永安药业股价,永安药业股市,永安药业股票价格,永安药业股票交易,永安药业股票购买,永安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供永安药业(002365)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}